ARCHIMED - Arkstone

July 2025
Buyer

France

Seller

United States

About the transaction

Arkstone is a biotechnology company providing clinical decision support powered by ML and AI, helping healthcare providers optimize antimicrobial use. Arkstone's OneChoice Report empowers clinicians to prescribe with precision and confidence, fighting antimicrobial resistance and democratizing infectious disease expertise.

Transaction assisted by

Manuel San Miguel

Manuel San Miguel

Senior Vice President
View profile
David Levine

David Levine

Regional Managing Director
View profile